adzenys xr-odt

Generic: amphetamine

Labeler: neos therapeutics brands, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name adzenys xr-odt
Generic Name amphetamine
Labeler neos therapeutics brands, llc
Dosage Form TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Active Ingredients

amphetamine 18.8 mg/1

Manufacturer
Neos Therapeutics Brands, LLC

Identifiers & Regulatory

Product NDC 70165-030
Product ID 70165-030_3f92012c-7250-9c32-e063-6394a90adb47
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA204326
DEA Schedule cii
Listing Expiration 2026-12-31
Marketing Start 2016-02-16

Pharmacologic Class

Established (EPC)
central nervous system stimulant [epc]
Physiologic Effect
central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70165030
Hyphenated Format 70165-030

Supplemental Identifiers

RxCUI
1739803 1739809 1739813 1739815 1739819 1739821 1739825 1739827 1739831 1739833 1739837 1739839
UPC
0370165015301 0370165010306 0370165030304 0370165005302 0370165025300 0370165020305
UNII
CK833KGX7E
NUI
N0000175739 N0000175729

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name adzenys xr-odt (source: ndc)
Generic Name amphetamine (source: ndc)
Application Number NDA204326 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 18.8 mg/1
source: ndc
Packaging
  • 30 BLISTER PACK in 1 CARTON (70165-030-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
source: ndc

Packages (1)

Ingredients (1)

amphetamine (18.8 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3f92012c-7250-9c32-e063-6394a90adb47", "openfda": {"nui": ["N0000175739", "N0000175729"], "upc": ["0370165015301", "0370165010306", "0370165030304", "0370165005302", "0370165025300", "0370165020305"], "unii": ["CK833KGX7E"], "rxcui": ["1739803", "1739809", "1739813", "1739815", "1739819", "1739821", "1739825", "1739827", "1739831", "1739833", "1739837", "1739839"], "spl_set_id": ["c1179269-00b5-48ea-972d-31e614e99b7e"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "manufacturer_name": ["Neos Therapeutics Brands, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (70165-030-30)  / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "70165-030-30", "marketing_start_date": "20160216"}], "brand_name": "Adzenys XR-ODT", "product_id": "70165-030_3f92012c-7250-9c32-e063-6394a90adb47", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "70165-030", "dea_schedule": "CII", "generic_name": "Amphetamine", "labeler_name": "Neos Therapeutics Brands, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adzenys XR-ODT", "active_ingredients": [{"name": "AMPHETAMINE", "strength": "18.8 mg/1"}], "application_number": "NDA204326", "marketing_category": "NDA", "marketing_start_date": "20160216", "listing_expiration_date": "20261231"}